• portfolio

homepage |
 SillaJen, Inc. is a privately-held biotechnology company focused on engineering and developing best-in-class oncolytic virus immunotherapeutics, with its most advanced product in Phase 3 clinical trials for liver cancer. SillaJen’s US affiliate, SillaJen Biotherapeutics, Inc., manages Clinical Operations, R&D, regulatory affairs and manufacturing capabilities. SillaJen Biotherapeutics is located in San Francisco, California.  

맨처음이전 1 다음맨뒤로